A Comparison of Sustained and Extended Release Bupropion Following Bariatric Surgery

Phase 4 Completed 20 enrolled North Dakota State University Neuropsychiatric Research Institute, Fargo, North Dakota · collab

RandomizedCrossoverOpen-label

Summary

This study is being conducted to evaluate how the body absorbs and processes the sustained release (SR) and extended release (XL) medication bupropion (Wellbutrin®). Subject who are 1-3 years post gastric bypass surgery will be invited to participate. Non-surgical controls will also be enrolled based on a matching criteria to post gastric bypass subjects. Participants will be asked to complete two 12-hour study days approximately 11 days apart.

Timeline

Start: 2014-06
Primary completion: 2015-02
Completion: 2015-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bupropion	Small molecule	—	—

Indications

No indication recorded.